Skip to main content
TipRanks
Go Ultimate75% OFF

AlzeCure Pharma AB (AC6) Stock Statistics & Valuation Metrics

3 Followers

Total Valuation

AlzeCure Pharma AB has a market cap or net worth of EUR 79.47M. The enterprise value is EUR 849.11M.

Market Cap
EUR 79.47M
Enterprise Value
EUR 849.11M

Share Statistics

AlzeCure Pharma AB has 137,897,340 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
137,897,340
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

AlzeCure Pharma AB’s return on equity (ROE) is -1.45 and return on invested capital (ROIC) is -139.15%.

Return on Equity (ROE)
-1.45
Return on Assets (ROA)
-0.81
Return on Invested Capital (ROIC)
-139.15%
Return on Capital Employed (ROCE)
-1.39
Revenue Per Employee
0
Profits Per Employee
-4.77M
Employee Count
10
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of AlzeCure Pharma AB is 10.67. AlzeCure Pharma AB’s PEG ratio is 0.02.

PE Ratio
10.67
PS Ratio
5.40
PB Ratio
4.23
Price to FCF
8.57
Price to Operating Cash Flow
8.99
PEG Ratio
0.02

Income Statement

In the last 12 months, AlzeCure Pharma AB had revenue of 0 and earned -47.65M in profits. Earnings per share was -0.47.

Revenue
0
Gross Profit
-1.27M
Operating Income
-49.37M
Pretax Income
-47.67M
Net Income
-47.65M
EBITDA
-48.10M
Earnings Per Share (EPS)
-0.47

Cash Flow

In the last 12 months, operating cash flow was 110.55M and capital expenditures 0, giving a free cash flow of 110.55M billion.

Operating Cash Flow
110.55M
Free Cash Flow
110.55M
Free Cash Flow per Share
0.71

Dividends & Yields

AlzeCure Pharma AB pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
11.66%
Earnings Yield
10.06%

Stock Price Statistics

Beta
-0.37
52-Week Price Change
335.77%
50-Day Moving Average
0.60
200-Day Moving Average
0.36
Relative Strength Index (RSI)
46.15
Average Volume (3m)
1,354

Important Dates

AlzeCure Pharma AB upcoming earnings date is Feb 23, 2027, Before Open (Not Confirmed).

Last Earnings Date
Nov 11, 2026
Next Earnings Date
Feb 23, 2027
Ex-Dividend Date
―

Financial Position

AlzeCure Pharma AB as a current ratio of 2.33, with Debt / Equity ratio of 15.55%

Current Ratio
2.33
Quick Ratio
2.33
Debt to Market Cap
0.01
Net Debt to EBITDA
0.94
Interest Coverage Ratio
-180.85

Taxes

In the past 12 months, AlzeCure Pharma AB has paid 18.00K in taxes.

Income Tax
18.00K
Effective Tax Rate
-0.00

Enterprise Valuation

AlzeCure Pharma AB EV to EBITDA ratio is 7.32, with an EV/FCF ratio of 6.34.

EV to Sales
3.99
EV to EBITDA
7.32
EV to Free Cash Flow
6.34
EV to Operating Cash Flow
6.34

Balance Sheet

AlzeCure Pharma AB has EUR 231.93M in cash and marketable securities with EUR 1.72M in debt, giving a net cash position of EUR 230.22M billion.

Cash & Marketable Securities
EUR 231.93M
Total Debt
EUR 1.72M
Net Cash
EUR 230.22M
Net Cash Per Share
EUR 1.67
Tangible Book Value Per Share
EUR 1.51

Margins

Gross margin is 59.15%, with operating margin of 53.77%, and net profit margin of 56.88%.

Gross Margin
59.15%
Operating Margin
53.77%
Pretax Margin
56.88%
Net Profit Margin
56.88%
EBITDA Margin
54.51%
EBIT Margin
53.77%